Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients With Type 2 Diabetes: Single-Blind Interventional Study With Placebo Control at Tertiary Care Setting Quetta. L&S 2025, 6 (4), 06. https://doi.org/10.37185/LnS.1.1.870.